Advanced HIV disease and its predictors among newly diagnosed PLHIV in the Gedeo zone, southern Ethiopia

Globally, HIV infection remains a leading cause of morbidity and mortality. Despite reducing new infections, the global response to advanced HIV disease (AHD) remains ineffective, leaving HIV epidemics a significant public health threat worldwide. In Ethiopia, evidence regarding AHD is scarce. There...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2024-09, Vol.19 (9), p.e0310373
Hauptverfasser: Lerango, Temesgen Leka, Markos, Tesfalidet, Yehualeshet, Daniel, Kefyalew, Endashaw, Lerango, Semalgn Leka
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 9
container_start_page e0310373
container_title PloS one
container_volume 19
creator Lerango, Temesgen Leka
Markos, Tesfalidet
Yehualeshet, Daniel
Kefyalew, Endashaw
Lerango, Semalgn Leka
description Globally, HIV infection remains a leading cause of morbidity and mortality. Despite reducing new infections, the global response to advanced HIV disease (AHD) remains ineffective, leaving HIV epidemics a significant public health threat worldwide. In Ethiopia, evidence regarding AHD is scarce. Therefore, this study aimed to assess the prevalence and predictors of AHD among newly diagnosed people living with HIV (PLHIV) initiating antiretroviral therapy in the Gedeo zone, southern Ethiopia. A facility-based cross-sectional study was conducted from May 29, 2023, to February 06, 2024, at health facilities providing HIV care in the Gedeo zone, southern Ethiopia. A total of 427 PLHIV-initiating antiretroviral therapy (ART) were recruited for the study. The data were collected through face-to-face interviews and record reviews using KoboCollect version 2.4 and analyzed using R version 4.3.3. The Akaike information criterion (AIC) model selection was used to evaluate and choose the best-fitting model to describe the relationship between AHD and predictors. Finally, variables with a p-value less than 0.05 were considered independent predictors in the multivariable regression analysis. The study participants' mean (±SD) age was 31.3 (±8.7) years. The overall prevalence of AHD among newly diagnosed PLHIV-initiating ART was 34.4% (95% CI: 29.8%, 39.1%). Rural residence (AOR = 3.48, 95% CI: 2.24, 5.47), alcohol consumption (AOR = 2.48, 95% CI: 1.59, 3.90), and being identified through community-based index case testing (ICT) (AOR = 0.26, 95% CI: 0.13, 0.51) were found to be independent predictors of AHD. The prevalence of AHD among newly diagnosed individuals initiating ART was high. PLHIV who consume alcohol should receive detailed counseling on how it can negatively impact their progress with antiretroviral treatment. HIV testing should be enhanced in rural communities by strengthening community health campaigns. Furthermore, community-based index case testing should be strengthened for early identification of PLHIV.
doi_str_mv 10.1371/journal.pone.0310373
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3104450033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A808610436</galeid><sourcerecordid>A808610436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-5c59a3d2164d810256600872ae20cab2c00f9b43553f268bcea0161b1c3d1d1c3</originalsourceid><addsrcrecordid>eNqN0u9r1DAYB_AiipvT_0A0IIiCd-ZHm7YvjzG3g4OJP_Y2pMnTa0abdEmqzr_eHNfJTvZCCm0Jn-_T8uXJspcELwkrycdrN3kr--XoLCwxI5iV7FF2TGpGF5xi9vje-1H2LIRrjAtWcf40O2I15XXNiuOsW-kf0irQ6GJ9hbQJIAMgaTUyMaDRgzYqOh-QHJzdIgs_-9vE5Na6kEKfN7uYsSh2gM5Bg0O_0_98QMFN6chbdBY740Yjn2dPWtkHeDE_T7Lvn86-nV4sNpfn69PVZqHyAsdFoYpaMk0Jz3VFMC04x7gqqQSKlWyowritm5wVBWsprxoFEhNOGqKYJjrdT7LX-7lj74KYSwoi9ZOnD2DGkng3C-9uJghRDCYo6HtpwU17WrAyL2mib_6hDw-c1Vb2IIxtXfRS7YaKVYUrniTjSS0fUOnSMBiVSmtNOj8IvD8IJBPhV9zKKQSx_vrl_-3l1aF9e892IPvYBddP0TgbDmG-h8q7EDy0YvRmkP5WECx2O3jXhtjtoJh3MMVezaVNzQD6b-hu6dgfNhbTqw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3104450033</pqid></control><display><type>article</type><title>Advanced HIV disease and its predictors among newly diagnosed PLHIV in the Gedeo zone, southern Ethiopia</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Lerango, Temesgen Leka ; Markos, Tesfalidet ; Yehualeshet, Daniel ; Kefyalew, Endashaw ; Lerango, Semalgn Leka</creator><contributor>McCreesh, Nicky</contributor><creatorcontrib>Lerango, Temesgen Leka ; Markos, Tesfalidet ; Yehualeshet, Daniel ; Kefyalew, Endashaw ; Lerango, Semalgn Leka ; McCreesh, Nicky</creatorcontrib><description>Globally, HIV infection remains a leading cause of morbidity and mortality. Despite reducing new infections, the global response to advanced HIV disease (AHD) remains ineffective, leaving HIV epidemics a significant public health threat worldwide. In Ethiopia, evidence regarding AHD is scarce. Therefore, this study aimed to assess the prevalence and predictors of AHD among newly diagnosed people living with HIV (PLHIV) initiating antiretroviral therapy in the Gedeo zone, southern Ethiopia. A facility-based cross-sectional study was conducted from May 29, 2023, to February 06, 2024, at health facilities providing HIV care in the Gedeo zone, southern Ethiopia. A total of 427 PLHIV-initiating antiretroviral therapy (ART) were recruited for the study. The data were collected through face-to-face interviews and record reviews using KoboCollect version 2.4 and analyzed using R version 4.3.3. The Akaike information criterion (AIC) model selection was used to evaluate and choose the best-fitting model to describe the relationship between AHD and predictors. Finally, variables with a p-value less than 0.05 were considered independent predictors in the multivariable regression analysis. The study participants' mean (±SD) age was 31.3 (±8.7) years. The overall prevalence of AHD among newly diagnosed PLHIV-initiating ART was 34.4% (95% CI: 29.8%, 39.1%). Rural residence (AOR = 3.48, 95% CI: 2.24, 5.47), alcohol consumption (AOR = 2.48, 95% CI: 1.59, 3.90), and being identified through community-based index case testing (ICT) (AOR = 0.26, 95% CI: 0.13, 0.51) were found to be independent predictors of AHD. The prevalence of AHD among newly diagnosed individuals initiating ART was high. PLHIV who consume alcohol should receive detailed counseling on how it can negatively impact their progress with antiretroviral treatment. HIV testing should be enhanced in rural communities by strengthening community health campaigns. Furthermore, community-based index case testing should be strengthened for early identification of PLHIV.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0310373</identifier><identifier>PMID: 39269935</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acquired immune deficiency syndrome ; Adult ; AIDS ; Anti-HIV Agents - therapeutic use ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Care and treatment ; Cross-Sectional Studies ; Disease prevention ; Drug therapy ; Epidemics ; Ethiopia - epidemiology ; Female ; Health care facilities ; Health facilities ; Health promotion ; Health risks ; HIV ; HIV (Viruses) ; HIV Infections - diagnosis ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; Hospitals ; Human immunodeficiency virus ; Humans ; Independent variables ; Infections ; Male ; Medical care ; Medical diagnosis ; Middle Aged ; Morbidity ; Patient outcomes ; Personal health ; Prevalence ; Public health ; Quality management ; Regression analysis ; Risk Factors ; Rural areas ; Rural communities ; Variables ; Young Adult</subject><ispartof>PloS one, 2024-09, Vol.19 (9), p.e0310373</ispartof><rights>Copyright: © 2024 Lerango et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Lerango et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Lerango et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c450t-5c59a3d2164d810256600872ae20cab2c00f9b43553f268bcea0161b1c3d1d1c3</cites><orcidid>0000-0002-9016-5284 ; 0000-0002-9375-0219</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0310373&amp;type=printable$$EPDF$$P50$$Gplos$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0310373$$EHTML$$P50$$Gplos$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,864,2926,23865,27923,27924,79371,79372</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39269935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>McCreesh, Nicky</contributor><creatorcontrib>Lerango, Temesgen Leka</creatorcontrib><creatorcontrib>Markos, Tesfalidet</creatorcontrib><creatorcontrib>Yehualeshet, Daniel</creatorcontrib><creatorcontrib>Kefyalew, Endashaw</creatorcontrib><creatorcontrib>Lerango, Semalgn Leka</creatorcontrib><title>Advanced HIV disease and its predictors among newly diagnosed PLHIV in the Gedeo zone, southern Ethiopia</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Globally, HIV infection remains a leading cause of morbidity and mortality. Despite reducing new infections, the global response to advanced HIV disease (AHD) remains ineffective, leaving HIV epidemics a significant public health threat worldwide. In Ethiopia, evidence regarding AHD is scarce. Therefore, this study aimed to assess the prevalence and predictors of AHD among newly diagnosed people living with HIV (PLHIV) initiating antiretroviral therapy in the Gedeo zone, southern Ethiopia. A facility-based cross-sectional study was conducted from May 29, 2023, to February 06, 2024, at health facilities providing HIV care in the Gedeo zone, southern Ethiopia. A total of 427 PLHIV-initiating antiretroviral therapy (ART) were recruited for the study. The data were collected through face-to-face interviews and record reviews using KoboCollect version 2.4 and analyzed using R version 4.3.3. The Akaike information criterion (AIC) model selection was used to evaluate and choose the best-fitting model to describe the relationship between AHD and predictors. Finally, variables with a p-value less than 0.05 were considered independent predictors in the multivariable regression analysis. The study participants' mean (±SD) age was 31.3 (±8.7) years. The overall prevalence of AHD among newly diagnosed PLHIV-initiating ART was 34.4% (95% CI: 29.8%, 39.1%). Rural residence (AOR = 3.48, 95% CI: 2.24, 5.47), alcohol consumption (AOR = 2.48, 95% CI: 1.59, 3.90), and being identified through community-based index case testing (ICT) (AOR = 0.26, 95% CI: 0.13, 0.51) were found to be independent predictors of AHD. The prevalence of AHD among newly diagnosed individuals initiating ART was high. PLHIV who consume alcohol should receive detailed counseling on how it can negatively impact their progress with antiretroviral treatment. HIV testing should be enhanced in rural communities by strengthening community health campaigns. Furthermore, community-based index case testing should be strengthened for early identification of PLHIV.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>AIDS</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Care and treatment</subject><subject>Cross-Sectional Studies</subject><subject>Disease prevention</subject><subject>Drug therapy</subject><subject>Epidemics</subject><subject>Ethiopia - epidemiology</subject><subject>Female</subject><subject>Health care facilities</subject><subject>Health facilities</subject><subject>Health promotion</subject><subject>Health risks</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Independent variables</subject><subject>Infections</subject><subject>Male</subject><subject>Medical care</subject><subject>Medical diagnosis</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Patient outcomes</subject><subject>Personal health</subject><subject>Prevalence</subject><subject>Public health</subject><subject>Quality management</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Rural areas</subject><subject>Rural communities</subject><subject>Variables</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqN0u9r1DAYB_AiipvT_0A0IIiCd-ZHm7YvjzG3g4OJP_Y2pMnTa0abdEmqzr_eHNfJTvZCCm0Jn-_T8uXJspcELwkrycdrN3kr--XoLCwxI5iV7FF2TGpGF5xi9vje-1H2LIRrjAtWcf40O2I15XXNiuOsW-kf0irQ6GJ9hbQJIAMgaTUyMaDRgzYqOh-QHJzdIgs_-9vE5Na6kEKfN7uYsSh2gM5Bg0O_0_98QMFN6chbdBY740Yjn2dPWtkHeDE_T7Lvn86-nV4sNpfn69PVZqHyAsdFoYpaMk0Jz3VFMC04x7gqqQSKlWyowritm5wVBWsprxoFEhNOGqKYJjrdT7LX-7lj74KYSwoi9ZOnD2DGkng3C-9uJghRDCYo6HtpwU17WrAyL2mib_6hDw-c1Vb2IIxtXfRS7YaKVYUrniTjSS0fUOnSMBiVSmtNOj8IvD8IJBPhV9zKKQSx_vrl_-3l1aF9e892IPvYBddP0TgbDmG-h8q7EDy0YvRmkP5WECx2O3jXhtjtoJh3MMVezaVNzQD6b-hu6dgfNhbTqw</recordid><startdate>20240913</startdate><enddate>20240913</enddate><creator>Lerango, Temesgen Leka</creator><creator>Markos, Tesfalidet</creator><creator>Yehualeshet, Daniel</creator><creator>Kefyalew, Endashaw</creator><creator>Lerango, Semalgn Leka</creator><general>Public Library of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9016-5284</orcidid><orcidid>https://orcid.org/0000-0002-9375-0219</orcidid></search><sort><creationdate>20240913</creationdate><title>Advanced HIV disease and its predictors among newly diagnosed PLHIV in the Gedeo zone, southern Ethiopia</title><author>Lerango, Temesgen Leka ; Markos, Tesfalidet ; Yehualeshet, Daniel ; Kefyalew, Endashaw ; Lerango, Semalgn Leka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-5c59a3d2164d810256600872ae20cab2c00f9b43553f268bcea0161b1c3d1d1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>AIDS</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Care and treatment</topic><topic>Cross-Sectional Studies</topic><topic>Disease prevention</topic><topic>Drug therapy</topic><topic>Epidemics</topic><topic>Ethiopia - epidemiology</topic><topic>Female</topic><topic>Health care facilities</topic><topic>Health facilities</topic><topic>Health promotion</topic><topic>Health risks</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Independent variables</topic><topic>Infections</topic><topic>Male</topic><topic>Medical care</topic><topic>Medical diagnosis</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Patient outcomes</topic><topic>Personal health</topic><topic>Prevalence</topic><topic>Public health</topic><topic>Quality management</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Rural areas</topic><topic>Rural communities</topic><topic>Variables</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lerango, Temesgen Leka</creatorcontrib><creatorcontrib>Markos, Tesfalidet</creatorcontrib><creatorcontrib>Yehualeshet, Daniel</creatorcontrib><creatorcontrib>Kefyalew, Endashaw</creatorcontrib><creatorcontrib>Lerango, Semalgn Leka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lerango, Temesgen Leka</au><au>Markos, Tesfalidet</au><au>Yehualeshet, Daniel</au><au>Kefyalew, Endashaw</au><au>Lerango, Semalgn Leka</au><au>McCreesh, Nicky</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advanced HIV disease and its predictors among newly diagnosed PLHIV in the Gedeo zone, southern Ethiopia</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-09-13</date><risdate>2024</risdate><volume>19</volume><issue>9</issue><spage>e0310373</spage><pages>e0310373-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Globally, HIV infection remains a leading cause of morbidity and mortality. Despite reducing new infections, the global response to advanced HIV disease (AHD) remains ineffective, leaving HIV epidemics a significant public health threat worldwide. In Ethiopia, evidence regarding AHD is scarce. Therefore, this study aimed to assess the prevalence and predictors of AHD among newly diagnosed people living with HIV (PLHIV) initiating antiretroviral therapy in the Gedeo zone, southern Ethiopia. A facility-based cross-sectional study was conducted from May 29, 2023, to February 06, 2024, at health facilities providing HIV care in the Gedeo zone, southern Ethiopia. A total of 427 PLHIV-initiating antiretroviral therapy (ART) were recruited for the study. The data were collected through face-to-face interviews and record reviews using KoboCollect version 2.4 and analyzed using R version 4.3.3. The Akaike information criterion (AIC) model selection was used to evaluate and choose the best-fitting model to describe the relationship between AHD and predictors. Finally, variables with a p-value less than 0.05 were considered independent predictors in the multivariable regression analysis. The study participants' mean (±SD) age was 31.3 (±8.7) years. The overall prevalence of AHD among newly diagnosed PLHIV-initiating ART was 34.4% (95% CI: 29.8%, 39.1%). Rural residence (AOR = 3.48, 95% CI: 2.24, 5.47), alcohol consumption (AOR = 2.48, 95% CI: 1.59, 3.90), and being identified through community-based index case testing (ICT) (AOR = 0.26, 95% CI: 0.13, 0.51) were found to be independent predictors of AHD. The prevalence of AHD among newly diagnosed individuals initiating ART was high. PLHIV who consume alcohol should receive detailed counseling on how it can negatively impact their progress with antiretroviral treatment. HIV testing should be enhanced in rural communities by strengthening community health campaigns. Furthermore, community-based index case testing should be strengthened for early identification of PLHIV.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>39269935</pmid><doi>10.1371/journal.pone.0310373</doi><tpages>e0310373</tpages><orcidid>https://orcid.org/0000-0002-9016-5284</orcidid><orcidid>https://orcid.org/0000-0002-9375-0219</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2024-09, Vol.19 (9), p.e0310373
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_3104450033
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Acquired immune deficiency syndrome
Adult
AIDS
Anti-HIV Agents - therapeutic use
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Care and treatment
Cross-Sectional Studies
Disease prevention
Drug therapy
Epidemics
Ethiopia - epidemiology
Female
Health care facilities
Health facilities
Health promotion
Health risks
HIV
HIV (Viruses)
HIV Infections - diagnosis
HIV Infections - drug therapy
HIV Infections - epidemiology
Hospitals
Human immunodeficiency virus
Humans
Independent variables
Infections
Male
Medical care
Medical diagnosis
Middle Aged
Morbidity
Patient outcomes
Personal health
Prevalence
Public health
Quality management
Regression analysis
Risk Factors
Rural areas
Rural communities
Variables
Young Adult
title Advanced HIV disease and its predictors among newly diagnosed PLHIV in the Gedeo zone, southern Ethiopia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T13%3A49%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advanced%20HIV%20disease%20and%20its%20predictors%20among%20newly%20diagnosed%20PLHIV%20in%20the%20Gedeo%20zone,%20southern%20Ethiopia&rft.jtitle=PloS%20one&rft.au=Lerango,%20Temesgen%20Leka&rft.date=2024-09-13&rft.volume=19&rft.issue=9&rft.spage=e0310373&rft.pages=e0310373-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0310373&rft_dat=%3Cgale_plos_%3EA808610436%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3104450033&rft_id=info:pmid/39269935&rft_galeid=A808610436&rfr_iscdi=true